William Greenhalf Selected Research

William Greenhalf Research Topics

Disease

31	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 05/2004
21	Neoplasms (Cancer) 01/2022 - 04/2005
15	Adenocarcinoma 02/2020 - 05/2004
10	Chronic Pancreatitis 12/2020 - 01/2009
8	Pancreatitis 10/2019 - 12/2004
4	Neoplasm Metastasis (Metastasis) 06/2017 - 04/2005
3	Carcinogenesis 01/2021 - 08/2012
3	Hereditary pancreatitis 07/2020 - 03/2004
3	Pancreatic Diseases (Pancreatic Disease) 11/2015 - 04/2013
2	COVID-19 01/2022 - 11/2021
2	Cystic Fibrosis (Mucoviscidosis) 03/2020 - 01/2020
2	Exocrine Pancreatic Insufficiency 10/2019 - 01/2019
2	Neutropenia 01/2017 - 07/2014
2	Fatigue 01/2017 - 07/2014
2	Diabetes Mellitus 04/2016 - 01/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Infections 11/2021
1	Digestive System Diseases 12/2020
1	Urologic Neoplasms (Urological Cancer) 12/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Disease Progression 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2016
1	Alcoholic Pancreatitis 01/2016
1	Inflammation (Inflammations) 08/2014
1	Necrosis 08/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2014
1	Pain (Aches) 07/2014

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2009
10	Gemcitabine FDA Link 11/2021 - 05/2004
5	TrypsinogenIBA 12/2012 - 03/2004
4	Fluorouracil (Carac)FDA LinkGeneric 11/2021 - 05/2004
4	Proteins (Proteins, Gene)FDA Link 12/2016 - 05/2015
3	Indicators and Reagents (Reagents)IBA 01/2022 - 04/2005
3	Kazal Pancreatic Trypsin InhibitorIBA 07/2020 - 12/2012
3	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2015 - 01/2011
3	EnzymesIBA 08/2014 - 06/2011
2	molnupiravirIBA 01/2022 - 11/2021
2	NucleosidesIBA 01/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 11/2021 - 01/2020
2	Rosuvastatin Calcium (Crestor)FDA Link 03/2020 - 01/2020
2	AminoglycosidesIBA 03/2020 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2012
2	Capecitabine (Xeloda)FDA Link 03/2016 - 07/2014
2	EstersIBA 01/2016 - 08/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2016 - 08/2014
2	Cyclin-Dependent Kinase Inhibitor p16IBA 06/2005 - 05/2004
1	AdiponectinIBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	AntibodiesIBA 01/2022
1	ProdrugsIBA 01/2022
1	Cytidine DeaminaseIBA 11/2021
1	Long Noncoding RNAIBA 01/2021
1	Cathepsin DIBA 02/2020
1	Peptide Hydrolases (Proteases)FDA Link 02/2020
1	LigandsIBA 02/2020
1	SmokeIBA 01/2020
1	CollagenIBA 01/2019
1	Amylases FDA Link 01/2019
1	Collagen Type I (Type I Collagen)IBA 11/2018
1	Galectin 1 (LGALS1)IBA 08/2018
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 08/2018
1	CTLA-4 AntigenIBA 06/2017
1	RNA (Ribonucleic Acid)IBA 06/2017
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 06/2017
1	(N- Ac- His(1)- Nle(17)- Arg(20,21)- Ala(26))- vasoactive intestinal peptideIBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	GATA Transcription FactorsIBA 01/2017
1	vandetanib (ZD6474)IBA 01/2017
1	Pimozide (Orap)FDA Link 12/2016
1	Haloperidol (Haldol)FDA LinkGeneric 12/2016
1	Thrombospondin 1IBA 04/2016
1	Interleukin-6 (Interleukin 6)IBA 03/2016
1	C-Reactive ProteinIBA 03/2016
1	VaccinesIBA 03/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2016
1	Choline KinaseIBA 02/2016
1	Lipase (Acid Lipase)FDA Link 01/2016
1	telomerase RNA (bTR)IBA 11/2015
1	ProteomeIBA 08/2015
1	Albumin-Bound Paclitaxel FDA Link 05/2015
1	Diclofenac (SR 38)FDA LinkGeneric 03/2015
1	3-benzyl-6-chloro-2-pyroneIBA 08/2014
1	4-methylpiperazine-2,6-dioneIBA 08/2014
1	NAD (NADH)IBA 08/2014
1	Carboxylesterase (Hydrolase S)IBA 08/2014
1	Ethanol (Ethyl Alcohol)IBA 08/2014
1	fatty acyl ethyl ester synthaseIBA 08/2014
1	Protein Subunit VaccinesIBA 07/2014
1	Interleukin-8 (Interleukin 8)IBA 05/2014

Therapy/Procedure

5	Therapeutics 02/2020 - 10/2008
4	Adjuvant Chemotherapy 01/2022 - 10/2008
3	Drug Therapy (Chemotherapy) 01/2018 - 07/2014
1	Intravenous Infusions 01/2017
1	Combination Drug Therapy (Combination Chemotherapy) 03/2016
1	Stents 03/2015